Latest news

Pfizer Allays Concern about its Animal Health Products

Friday May 9, 2003

Pfizer Australia, the country’s leading animal heathcare company, has moved to allay potential concerns about its products, none of which are involved in the Pan Pharmaceuticals recall.

Pfizer Australia says NO products made or marketed by it and its new affiliate company, Pharmacia Australia, are affected. Pan Pharmaceuticals is not a supplier of either company.

Pfizer Australian Animal Health Group Business Director, Dr Vincent Guyonnet, said there was some potential public confusion about the status of animal healthcare products.

“Veterinarians, livestock producers and pet owners using products under the Pfizer Australia or Pharmacia Australia banners can be confident they had been produced to the strictest standards”
said Dr Guyonnet.

Pfizer Australia markets Canex*, Clavulox*, Cue-Mate*, Dectomax*, Felex*, Mastalone*, Orbenin*, RespiSure* / RespiSure One*, Revolution*, Rimadyl*, Teatseal*, Terramycin* , Valbazen* and Vibravet*.

Pharmacia Australia markets Antirobe*, CIDR*, Eazi-Breed CIDR*, Delta-Albaplex*, Delta-Cortef*, Depo-Medrol*, Durodry*, Excenel*, Lincocin*, Lincocin Forte*, Lincomix*, Linco Spectin*, Lutalyse*, Solu-Delta-Cortef* and Special Formula*.

Pfizer Australia is the nation’s leading research-based health care company. It discovers, develops, manufactures and markets innovative medical treatments for both humans and animals.